Sponsor:
ImmunityBio, Inc.
Code:
NCT05618925
Conditions
Non Hodgkin's Lymphoma Refractory/Relapsed
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
N803
CD19t-haNK suspension
Cyclophosphamide
Fludarabine
Rituximab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations